ArticleCancer control : journal of the Moffitt Cancer Center

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial.

Xianzhi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.